Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators (Q73290256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J N Cohn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Tognoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Glazer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Spormann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

439-446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Relation between gender, etiology and survival in patients with symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900130-6

7 January 2021

10.1016/S1388-9842(00)00130-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11113722%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference